Novel compounds of the formula I in which W, X, Y, T, R
1
and R
2
are as defined in Patent claim
1,
are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic disorders.
1
公式I中的新化合物,其中W、X、Y、T、R1和R2如专利权要求1所定义,是
凝血因子Xa的
抑制剂,可用于预防和/或治疗血栓栓塞疾病。